Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Edmond DE Rothschild Holding S.A.

DENTSPLY SIRONA logo with Medical background
Remove Ads

Edmond DE Rothschild Holding S.A. boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 41.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,304,100 shares of the medical instruments supplier's stock after buying an additional 672,200 shares during the period. Edmond DE Rothschild Holding S.A. owned 1.16% of DENTSPLY SIRONA worth $43,732,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB increased its position in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after acquiring an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after acquiring an additional 1,568 shares in the last quarter. Finally, Quarry LP lifted its position in shares of DENTSPLY SIRONA by 455.0% in the third quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier's stock valued at $82,000 after acquiring an additional 2,489 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts recently weighed in on XRAY shares. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Jefferies Financial Group lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Morgan Stanley dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research note on Tuesday, December 17th. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $23.33.

Check Out Our Latest Report on DENTSPLY SIRONA

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Up 1.5 %

NASDAQ:XRAY traded up $0.22 on Wednesday, reaching $14.87. The stock had a trading volume of 2,269,286 shares, compared to its average volume of 3,089,841. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $14.53 and a 12-month high of $33.02. The company has a 50-day moving average of $17.37 and a 200 day moving average of $19.93. The stock has a market cap of $2.96 billion, a P/E ratio of -7.18, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.30%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads